Researchers at the University of Maryland Medical Center have developed a new approach to treating long-term diabetic patients by transplanting their pancreas alone. The study found that using two new anti-rejection drugs, Prograf and Cellcept, resulted in a one-year pancreas survival rate of 77 percent for patients.
Researchers at Case Western Reserve University found that nicotine inhibits the formation of amyloid plaques, a toxic substance in Alzheimer's patients. The study suggests a potential link between nicotine and preventing or slowing down amyloid formation in AD patients.
A neural prosthetic system has been recommended for FDA approval, allowing paralyzed people to grasp objects without assistance. The system, developed over 25 years, enables users to regain hand function and perform routine activities with greater independence.
The University of Maryland Medical Center now offers a new therapy to prevent stroke disability using the FDA-approved drug Activase. This clot-busting treatment is administered intravenously and can significantly reduce disability risk for patients who receive it within three hours after symptom onset.